Verquvo (vericiguat)

pCPA File Number: 22399

Negotiation Status:

Active Negotiation

Indication(s):

For the treatment of symptomatic chronic heart failure in adult patients with reduced ejection fraction who are stabilized after a recent heart failure decompensation event requiring hospitalization and/or intravenous diuretic therapy

Sponsor/Manufacturer:

Bayer Inc.

CADTH Project Number:

SR0758

pCPA Engagement Letter Issued:

2023-12-18

Negotiation Process Concluded:

Not Applicable